What does a Down syndrome screening result below the established cutoff mean for a pregnant patient?

Screen-Negative Down Syndrome Result: Interpretation and Clinical Management

A Down syndrome screening result below the established cutoff indicates a screen-negative result, meaning the pregnancy has a lower calculated risk for trisomy 21 than the threshold (typically <1:250 or <1:270), but this does NOT eliminate the possibility of Down syndrome—it only provides reassurance that the risk is reduced compared to the baseline age-related risk. 1

Understanding What Screen-Negative Means

The negative predictive value (NPV) of first-trimester screening is high, correctly identifying the vast majority of unaffected pregnancies, but false-negative results do occur. 1 The key points to communicate:

• Screen-negative does NOT mean zero risk—it means the calculated risk falls below the predetermined cutoff threshold 1
• The residual risk depends on which screening test was performed and the patient's specific risk factors 1
• First-trimester combined screening (nuchal translucency + PAPP-A + free β-hCG) detects approximately 83-86% of Down syndrome cases at a 5% false-positive rate, meaning 14-17% of Down syndrome cases will have screen-negative results 2, 3

Performance Characteristics by Screening Method

The detection rate varies significantly by test type:

• First-trimester combined screening (NT + biochemistry): 83-86% detection rate, meaning 14-17% of Down syndrome cases are missed 2, 3
• Double marker alone (PAPP-A + free β-hCG without NT): ~70% detection rate, meaning 30% of cases are missed 3
• Second-trimester quadruple screen: 75-80% detection rate in women <35 years, >80% in women ≥35 years 3

The most critical clinical implication: even with optimal first-trimester combined screening, approximately 1 in 7 Down syndrome pregnancies will receive a screen-negative result. 2, 3

Essential Counseling Points for Screen-Negative Results

Risk Stratification After Negative Screen

Provide the patient with their specific calculated risk number, not just "negative" or "low risk." 1 For example:

• A 25-year-old with screen-negative combined test might have a final risk of 1:5,000
• A 38-year-old with screen-negative combined test might have a final risk of 1:800
• Both are "screen-negative" but carry vastly different residual risks 1

Factors That Can Cause False-Negative Results

Technical and biological factors that may lead to missed Down syndrome cases include: 4

• Inaccurate gestational age dating—using last menstrual period instead of ultrasound crown-rump length measurement significantly reduces accuracy 1, 4
• Inadequate nuchal translucency measurement technique—operator skill and certification are critical 1, 4
• Maternal factors not properly adjusted—weight, race, diabetes, smoking status must be incorporated into risk calculation 1
• Rare chromosomal rearrangements—such as Robertsonian translocations involving chromosome 21, which can cause false-negative results even with cell-free DNA testing 5
• Laboratory analytical errors—assay variability, incorrect median values, or software calculation errors 4

Clinical Management Algorithm for Screen-Negative Patients

For All Screen-Negative Patients

1. Document the specific calculated risk and screening method used (combined first-trimester, double marker, quadruple screen, etc.) 1

2. Ensure accurate gestational age dating via ultrasound crown-rump length, not hCG levels or last menstrual period alone 2

3. Perform detailed second-trimester anatomic ultrasound at 18-22 weeks—first-trimester screening detects 92% of trisomy 21 but only 0-15% of structural abnormalities 6

4. Counsel that screen-negative does not eliminate the need for second-trimester anatomic survey, as structural defects (cardiac, neural tube, skeletal) may be the only prenatal indicator of chromosomal abnormalities 6

For Screen-Negative Patients ≥35 Years

Women aged 35 and older should still be offered diagnostic testing (CVS or amniocentesis) regardless of screening results, as their baseline age-related risk remains elevated. 3 Specific considerations:

• A 35-year-old has a baseline term risk of ~1:380 for Down syndrome 1
• Even with screen-negative combined test, residual risk may be 1:500 to 1:1,000—still higher than many younger women's baseline risk 1
• Biochemical screening significantly reduces the screen-positive rate in women >35 years (from 56.3% based on age alone to 12.6% with biomarkers), making it valuable for avoiding unnecessary invasive procedures 7

For Screen-Negative Patients with Additional Risk Factors

Consider genetic counseling and possible diagnostic testing for: 1

• Family history of Down syndrome or other chromosomal abnormalities (may indicate familial translocation) 1
• Ultrasound findings suggestive of aneuploidy (increased nuchal fold, echogenic bowel, shortened long bones, cardiac defects) even with screen-negative biochemistry 6, 8
• Twin pregnancies—serum markers represent an average of both fetuses, reducing accuracy; NT measurement alone is more informative 3

Common Pitfalls to Avoid

Critical Errors in Interpretation

1. Never tell patients "the test is normal" or "your baby doesn't have Down syndrome"—screening tests assess risk, they do not diagnose 1

2. Do not skip second-trimester anatomic ultrasound based on screen-negative first-trimester results—85% of cardiac defects and most structural abnormalities are not detected by first-trimester screening 6

3. Do not use singleton cutoffs for twin pregnancies—specialized algorithms are required 3

4. Do not rely on last menstrual period dating—ultrasound crown-rump length at 11-13 weeks provides gestational age accurate to within 7 days 2

Reclassification Concerns

Be cautious when reclassifying screen-positive results to screen-negative based on revised dating—there is risk of reclassifying a true positive (fetus with Down syndrome) as false-negative. 1 This is primarily a concern for second-trimester screening and should be infrequent when nuchal translucency and crown-rump length measurements are included in first-trimester screening. 1

When to Consider Additional Testing Despite Screen-Negative Result

Second-trimester genetic sonography (detailed anatomic survey with aneuploidy markers) after screen-negative first-trimester combined test may improve detection but increases screen-positive rates: 8

• Integrated approach (applying sonographic markers to all patients) achieved 100% detection of trisomy 21 but at 22.7% screen-positive rate 8
• Stepwise sequential approach (applying sonographic markers only to screen-negative patients) also achieved 100% detection but at 28.3% screen-positive rate 8

Consider this approach for patients with high anxiety, advanced maternal age, or borderline screen-negative results (e.g., 1:260 when cutoff is 1:250). 8

Documentation Requirements

The laboratory report for screen-negative results should include: 1

• Patient identifiers and referring physician information 1
• Specific test performed and specimen type 1
• Date of sample collection and gestational age at sampling 1
• Demographic factors used in calculation (maternal age, weight, race, smoking status) 1
• Analytic results in both mass units and multiples of the median (MoM) 1
• Clinical interpretation stating "screen-negative," the risk cutoff level used, and the patient-specific calculated risk 1
• Clear statement that screen-negative does not eliminate risk and that diagnostic testing remains available 1

Screen-negative results can be transmitted by mail, courier, or electronic transmission, unlike screen-positive results which require prompt phone/fax notification within one working day. 1